{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T22:59:21Z","timestamp":1768777161486,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005154.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000}}],"reference-count":56,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005154.pub4","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T22:24:17Z","timestamp":1507847057000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia"],"prefix":"10.1002","volume":"2017","author":[{"given":"Samer","family":"Alabed","sequence":"first","affiliation":[{"name":"University of Sheffield; Academic Unit of Radiology; Sheffield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammar","family":"Sabouni","sequence":"additional","affiliation":[{"name":"Cairo University; KasrAlAiny School of Medicine; Cairo Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Providencia","sequence":"additional","affiliation":[{"name":"St Bartholomew's Hospital, Barts Health NHS Trust; Barts Heart Centre; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmond","family":"Atallah","sequence":"additional","affiliation":[{"name":"Nottingham University Hospitals NHS Trust; Department of Gastroenterology; Derby Road Nottingham East Midlands UK NG7 2UH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Qintar","sequence":"additional","affiliation":[{"name":"Saint Luke\u2019s Mid America Heart Institute; University of Missouri-Kansas City; Department of Cardiovascular Medicine; Kansas City MO USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy JA","family":"Chico","sequence":"additional","affiliation":[{"name":"University of Sheffield; Department of Infection, Immunity and Cardiovascular Disease; Sheffield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"key":"10.1002\/14651858.CD005154.pub4-BIB0001|cit1","first-page":"19","article-title":"Paroxysmal supraventricular tachycardia: efficacy of adenosine versus verapamil","volume":"42(Suppl 2)","author":"Cabrera-Sole","year":"1989","journal-title":"Revista Espanola de Cardiologia"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0002|cit2","first-page":"773","article-title":"A randomized, multicenter trial to compare the safety and efficacy of adenosine versus verapamil for termination of paroxysmal supraventricular tachycardia","volume":"42","author":"Cheng","year":"2003","journal-title":"Chinese Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0003|cit3","first-page":"55","article-title":"Adenosin-three phosphate compared with verapamil to treat paroxysmal supraventricular tachycardia","volume":"66","author":"Ferreira","year":"1996","journal-title":"Arquivos Brasileros de Cardiologia"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0004|cit4","first-page":"55","article-title":"Adenosin triphosphate and the treatment of paroxysmal supraventricular tachycardia: a comparison with verapamil","volume":"48","author":"Gil Madre","year":"1995","journal-title":"Revista Espanola de Cardiologia"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.CIR.66.3.504","article-title":"Treatment of paroxysmal supraventricular tachycardia in infancy with digitalis, adenosine-5'-triphosphate and verapamil: a comparative study","volume":"66","author":"Greco","year":"1982","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD005154.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.resuscitation.2009.01.017","article-title":"Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia","volume":"80","author":"Lim","year":"2009","journal-title":"Resuscitation"},{"issue":"6","key":"10.1002\/14651858.CD005154.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.plefa.2006.03.005","article-title":"Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardia","volume":"74","author":"Vranic","year":"2006","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"issue":"3","key":"10.1002\/14651858.CD005154.pub4-BIB0008|cit8","first-page":"492","article-title":"Comparison of efficacy of intravenous adenosine and verapamil in acute paroxysmal supraventricular tachycardia in adults","volume":"4","author":"Athar","year":"2013","journal-title":"Journal of Sheikh Zayed Medical College (JSZMC)"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ehj.2004.05.011","article-title":"Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia","volume":"25","author":"Ballo","year":"2004","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0002-9149(84)90334-5","article-title":"Acute management of supraventricular tachycardia: verapamil, adenosine triphosphate or adenosine?","volume":"54","author":"Belhassen","year":"1984","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0011|cit11","first-page":"499","article-title":"Adenosine triphosphate and the treatment of paroxysmal supraventricular tachycardia: a comparison with verapamil","volume":"48","author":"Conti Gimenez","year":"1995","journal-title":"Revista Espanola de Cardiologia"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-113-2-104","article-title":"Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials.","volume":"113","author":"DiMarco","year":"1990","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/0002-9149(89)90573-0","article-title":"Comparison of adenosine and verapamil for termination of paroxysmal junctional tachycardia","volume":"64","author":"Garratt","year":"1989","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD005154.pub4-BIB0014|cit14","first-page":"29","article-title":"Comparing the efficacy of intravenous adenosine and verapamil in termination of acute paroxysmal supra ventricular tachycardia","volume":"26","author":"Gill","year":"2014","journal-title":"Journal of Ayub Medical College Abbottabad"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/0002-8703(92)90807-8","article-title":"Adenosine versus verapamil in the treatment of supraventricular tachycardia: a randomized double-crossover trial","volume":"123","author":"Hood","year":"1992","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0016|cit16","first-page":"295","article-title":"Efficacy and safety of adenosine in termination of paroxysmal supraventricular tachycardia: comparison with verapamil","volume":"49","author":"Kulakowski","year":"1998","journal-title":"Kardiologia Polska"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/0003-4819-114-6-513","article-title":"Adenosine or verapamil for the acute treatment of supraventricular tachycardia?","volume":"114","author":"Rankin","year":"1991","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005154.pub4-BIB0018|cit18","first-page":"541","article-title":"Adenosine versus verapamil for the treatment of supra-ventricular tachycardia: randomized comparative trial","volume":"6","author":"Riaz","year":"2012","journal-title":"Pakistan Journal of Medical and Health Sciences"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0019|cit19","first-page":"283","article-title":"Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias","volume":"230","author":"Sellers","year":"1987","journal-title":"Progress in Clinical and Biological Research"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0020|cit20","first-page":"141","article-title":"Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia","volume":"46","author":"Sethi","year":"1994","journal-title":"Indian Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD005154.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1753944714553425","article-title":"Oral verapamil in paroxysmal supraventricular tachycardia recurrence control: a randomized clinical trial","volume":"9","author":"Shaker","year":"2015","journal-title":"Therapeutic Advances in Cardiovascular Disease"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s003900050072","article-title":"Acute management of supraventricular tachycardia: adenosine or ajmaline?","volume":"34","author":"Trappe","year":"1997","journal-title":"Intensivmedizin und Notfallmedizin"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0023|cit23","first-page":"452","article-title":"Effect of adenosine in termination of induced supraventricular tachycardias and comparison with verapamil","volume":"24","author":"Turkoglu","year":"1996","journal-title":"Turk Kardiyoloji Dernegi Arsivi"},{"issue":"4","key":"10.1002\/14651858.CD005154.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1542-474X.2009.00329.x","article-title":"Electrophysiologic characteristics of wide QRS complexes during pharmacologic termination of sustained supraventricular tachycardias with verapamil and adenosine: observations from electrophysiologic study","volume":"14","author":"Turkoglu","year":"2009","journal-title":"Annals of Noninvasive Electrocardiology"},{"issue":"18 Suppl 2","key":"10.1002\/14651858.CD005154.pub4-BIB0025|cit25","first-page":"S526","article-title":"Part 12: Pediatric advanced life support","volume":"132","author":"Caen","year":"2015","journal-title":"Circulation"},{"issue":"10005","key":"10.1002\/14651858.CD005154.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(15)61485-4","article-title":"Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial","volume":"386","author":"Appelboam","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"8","key":"10.1002\/14651858.CD005154.pub4-BIB0027|cit27","first-page":"1493","article-title":"ACC\/AHA\/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias--Executive Summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society","volume":"42","author":"Blomstrom-Lundqvist","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0028|cit28","first-page":"169","article-title":"Disturbances of cardiac rhythm and conduction","volume-title":"Emergency Medicine - a Comprehensive Study Guide","author":"Bolton","year":"2000"},{"issue":"7","key":"10.1002\/14651858.CD005154.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/anae.13126","article-title":"Calculating the probability of random sampling for continuous variables in submitted or published randomised controlled trials","volume":"70","author":"Carlisle","year":"2015","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0030|cit30","first-page":"n\/a","article-title":"Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals","volume":"n\/a","author":"Carlisle","year":"2017","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1039-51","DOI":"10.1056\/NEJMcp051145","article-title":"Supraventricular tachycardia","volume":"354","author":"Delacr\u00e9taz","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005154.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MEJ.0b013e3283400ba2","article-title":"The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis","volume":"18","author":"Delaney","year":"2011","journal-title":"European Journal of Emergency Medicine"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0002-9149(92)90196-6","article-title":"Acute conversion of paroxysmal supraventricular tachycardia. IV Diltiazem Study Group","volume":"70","author":"Dougherty","year":"1992","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2165\/00003495-199141040-00007","article-title":"Adenosine. An evaluation of its use in diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia","volume":"41","author":"Faulds","year":"1991","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/01.CIR.0000059743.36226.E8","article-title":"Contemporary management of paroxysmal supraventricular tachycardia","volume":"107","author":"Ferguson","year":"2003","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0036|cit36","unstructured":"Hamilton (ON): McMaster University (developed by Evidence Prime) GRADEproGDT 2015"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0037|cit37","first-page":"969","article-title":"Comparison of the efficacy of diltiazem and esmolol in terminating supraventricular tachycardia","volume":"47","author":"Gupta","year":"1999","journal-title":"Journal of the Association of Physicians of India"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0038|cit38","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0039|cit39","first-page":"855-73","article-title":"Supraventricular tachycardia, AV nodal reentry and Wolff-Parkinson-White syndrome","volume-title":"Hurst\u2019s The Heart","author":"Jayam","year":"2004"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9149(91)90706-Q","article-title":"Efficacy and safety of intravenous sotalol for termination of supraventricular tachycardia. The Sotalol Versus Placebo Multicenter Study Group","volume":"68","author":"Jordaens","year":"1991","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0041|cit41","first-page":"529","article-title":"Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias","volume":"43","author":"Joshi","year":"1995","journal-title":"Journal of the Association of Physicians of India"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0042|cit42","article-title":"Agents used in cardiac arrhythmias","volume-title":"Basic and Clinical Pharmacology","author":"Hondeghem","year":"1995"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0043|cit43","article-title":"Chapter 6: Searching for studies","volume-title":"Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Lefebvre","year":"2011"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0044|cit44","first-page":"423-44","article-title":"Acute and chronic pharmacologic management of supraventricular arrhythmias in cardiovascular therapeutics","volume-title":"Cardiovascular Therapeutics: A Companion to Braunwald\u2019s Heart Disease","author":"Mangrum","year":"2002"},{"issue":"5","key":"10.1002\/14651858.CD005154.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5694\/j.1326-5377.2009.tb02388.x","article-title":"Supraventricular tachycardia","volume":"190","author":"Medi","year":"2009","journal-title":"The Medical Journal of Australia"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0735-1097(97)00422-1","article-title":"Paroxysmal supraventricular tachycardia in the general population","volume":"31","author":"Orejarena","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"issue":"13","key":"10.1002\/14651858.CD005154.pub4-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.jacc.2015.08.856","article-title":"2015 ACC\/AHA\/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"67","author":"Page","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0048|cit48","unstructured":"Pitcher D Nolan J Peri-arrest arrhythmias https:\/\/www.resus.org.uk\/resuscitation-guidelines\/peri-arrest-arrhythmias\/ 2015 Version accessed 10 July 2016"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0049|cit49","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0050|cit50","article-title":"Chapter 11: Presenting results and \"Summary of findings\" tables","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Sch\u00fcnemann","year":"2011"},{"issue":"2","key":"10.1002\/14651858.CD005154.pub4-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009502.pub3","article-title":"Effectiveness of the Valsalva manoeuvre for reversion of supraventricular tachycardia","author":"Smith","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.resuscitation.2015.07.016","article-title":"European Resuscitation Council Guidelines for Resuscitation 2015: Section 3. Adult advanced life support","volume":"95","author":"Soar","year":"2015","journal-title":"Resuscitation"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0053|cit53","article-title":"Chapter 10: Addressing reporting biases","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sterne","year":"2011"},{"key":"10.1002\/14651858.CD005154.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/01.CIR.98.24.2716","article-title":"Electrophysiological mechanisms and determinants of vagal manoeuvres for termination of paroxysmal supraventricular tachycardia","volume":"98","author":"Wen","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD005154.pub4-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005154","article-title":"Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults","author":"Holdgate","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005154.pub4-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005154.pub2","article-title":"Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults","author":"Holdgate","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005154.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T09:08:31Z","timestamp":1697620111000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005154.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005154.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]}}}